2016 -- S 2294 SUBSTITUTE A

========

LC003117/SUB A

========

     STATE OF RHODE ISLAND

IN GENERAL ASSEMBLY

JANUARY SESSION, A.D. 2016

____________

A N   A C T

RELATING TO INSURANCE -- DRUG COVERAGE

     

     Introduced By: Senators Crowley, Sosnowski, Metts, and Miller

     Date Introduced: February 09, 2016

     Referred To: Senate Health & Human Services

     It is enacted by the General Assembly as follows:

1

     SECTION 1. Section 27-18-50 of the General Laws in Chapter 27-18 entitled "Accident

2

and Sickness Insurance Policies" is hereby amended to read as follows:

3

     27-18-50. Drug coverage. -- (a) Any accident and sickness insurer that utilizes a

4

formulary of medications for which coverage is provided under an individual or group plan

5

master contract shall require any physician or other person authorized by the department of health

6

to prescribe medication to prescribe from the formulary. A physician or other person authorized

7

by the department of health to prescribe medication shall be allowed to prescribe medications

8

previously on, or not on, the accident and sickness insurer's formulary if he or she believes that

9

the prescription of the non-formulary medication is medically necessary. An accident and

10

sickness insurer shall be required to provide coverage for a non-formulary medication only when

11

the non-formulary medication meets the accident and sickness insurer's medical exception criteria

12

for the coverage of that medication.

13

      (b) An accident and sickness insurer's medical exception criteria for the coverage of non-

14

formulary medications shall be developed in accordance with § 23-17.13-3(c)(3).

15

      (c) Any subscriber who is aggrieved by a denial of benefits to be provided under this

16

section may appeal the denial in accordance with the rules and regulations promulgated by the

17

department of health pursuant to chapter 17.12 of title 23.

18

     (d) Prior to removing a prescription drug from its plan's formulary or making any change

19

in the preferred or tiered cost-sharing status of a covered prescription drug, an accident and

 

1

sickness insurer must provide at least thirty (30) days' notice to authorized prescribers by

2

established communication methods of policy and program updates and by updating available

3

references on web-based publications. All affected members must be provided at least thirty (30)

4

days' notice prior to the date such change becomes effective by a direct notification:

5

     (i) The written or electronic notice must contain the following information:

6

     (A) The name of the affected prescription drug;

7

     (B) Whether the plan is removing the prescription drug from the formulary, or changing

8

its preferred or tiered cost-sharing status; and

9

      (C) The means by which subscribers may obtain a coverage determination or medical

10

exception, in the case of drugs that will require prior authorization or are formulary exclusions

11

respectively.

12

     (ii) An accident and sickness insurer may immediately remove from their plan

13

formularies covered prescription drugs deemed unsafe by the accident and sickness insurer or the

14

Food and Drug Administration, or removed from the market by their manufacturer, without

15

meeting the requirements of this section.

16

      (d)(e) This section shall not apply to insurance coverage providing benefits for: (1)

17

hospital confinement indemnity; (2) disability income; (3) accident only; (4) long term care; (5)

18

Medicare supplement; (6) limited benefit health; (7) specified disease indemnity; (8) sickness or

19

bodily injury or death by accident or both; or (9) other limited benefit policies.

20

     SECTION 2. Section 27-19-42 of the General Laws in Chapter 27-19 entitled "Nonprofit

21

Hospital Service Corporations" is hereby amended to read as follows:

22

     27-19-42. Drug coverage. -- (a) Any nonprofit hospital service corporation that utilizes a

23

formulary of medications for which coverage is provided under an individual or group plan

24

master contract shall require any physician or other person authorized by the department of health

25

to prescribe medication to prescribe from the formulary. A physician or other person authorized

26

by the department of health to prescribe medication shall be allowed to prescribe medications

27

previously on, or not on, the nonprofit hospital service corporation's formulary if he or she

28

believes that the prescription of the non-formulary medication is medically necessary. A

29

nonprofit hospital service corporation shall be required to provide coverage for a non-formulary

30

medication only when the non-formulary medication meets the nonprofit hospital service

31

corporation's medical exception criteria for the coverage of that medication.

32

      (b) A nonprofit hospital service corporation's medical exception criteria for the coverage

33

of non-formulary medications shall be developed in accordance with § 23-17.13-3(c)(3).

34

      (c) Any subscriber who is aggrieved by a denial of benefits to be provided under this

 

LC003117/SUB A - Page 2 of 6

1

section may appeal the denial in accordance with the rules and regulations promulgated by the

2

department of health pursuant to chapter 17.12 of title 23.

3

     (d) Prior to removing a prescription drug from its plan's formulary or making any change

4

in the preferred or tiered cost-sharing status of a covered prescription drug, a nonprofit hospital

5

service corporation must provide at least thirty (30) days' notice to authorized prescribers by

6

established communication methods of policy and program updates and by updating available

7

references on web-based publications. All affected members must be provided at least thirty (30)

8

days' notice prior to the date such change becomes effective by a direct notification:

9

     (i) The written or electronic notice must contain the following information:

10

     (A) The name of the affected prescription drug;

11

     (B) Whether the plan is removing the prescription drug from the formulary, or changing

12

its preferred or tiered cost-sharing status; and

13

     (C) The means by which subscribers may obtain a coverage determination or medical

14

exception, in the case of drugs that will require prior authorization or are formulary exclusions

15

respectively.

16

     (ii) A nonprofit hospital service corporation may immediately remove from their plan

17

formularies covered prescription drugs deemed unsafe by the nonprofit hospital service

18

corporation or the Food and Drug Administration, or removed from the market by their

19

manufacturer, without meeting the requirements of this section.

20

     SECTION 3. Section 27-20-37 of the General Laws in Chapter 27-20 entitled "Nonprofit

21

Medical Service Corporations" is hereby amended to read as follows:

22

     27-20-37. Drug coverage. -- (a) Any nonprofit medical service corporation that utilizes a

23

formulary of medications for which coverage is provided under an individual or group plan

24

master contract shall require any physician or other person authorized by the department of health

25

to prescribe medication to prescribe from the formulary. A physician or other person authorized

26

by the department of health to prescribe medication shall be allowed to prescribe medications

27

previously on, or not on, the nonprofit medical service corporation's formulary if he or she

28

believes that the prescription of the non-formulary medication is medically necessary. A

29

nonprofit hospital service corporation shall be required to provide coverage for a non-formulary

30

medication only when the non-formulary medication meets the nonprofit medical service

31

corporation's medical exception criteria for the coverage of that medication.

32

      (b) A nonprofit medical service corporation's medical exception criteria for the coverage

33

of non-formulary medications shall be developed in accordance with § 23-17.13-3(c)(3).

34

      (c) Any subscriber who is aggrieved by a denial of benefits to be provided under this

 

LC003117/SUB A - Page 3 of 6

1

section may appeal the denial in accordance with the rules and regulations promulgated by the

2

department of health pursuant to chapter 17.12 of title 23.

3

     (d) Prior to removing a prescription drug from its plan's formulary or making any change

4

in the preferred or tiered cost-sharing status of a covered prescription drug, a nonprofit medical

5

service corporation must provide at least thirty (30) days' notice to authorized prescribers by

6

established communication methods of policy and program updates and by updating available

7

references on web-based publications. All affected members must be provided at least thirty (30)

8

days' notice prior to the date such change becomes effective by a direct notification:

9

     (i) The written or electronic notice must contain the following information:

10

     (A) The name of the affected prescription drug;

11

     (B) Whether the plan is removing the prescription drug from the formulary, or changing

12

its preferred or tiered cost-sharing status; and

13

     (C) The means by which subscribers may obtain a coverage determination or medical

14

exception, in the case of drugs that will require prior authorization or are formulary exclusions

15

respectively.

16

     (ii) A nonprofit medical service corporation may immediately remove from their plan

17

formularies covered prescription drugs deemed unsafe by the nonprofit medical service

18

corporation or the Food and Drug Administration, or removed from the market by their

19

manufacturer, without meeting the requirements of this section.

20

     SECTION 4. Section 27-20.1-15 of the General Laws in Chapter 27-20.1 entitled

21

"Nonprofit Dental Service Corporations" is hereby amended to read as follows:

22

     27-20.1-15. Drug coverage. -- (a) Any nonprofit dental service corporation that utilizes a

23

formulary of medications for which coverage is provided under an individual or group plan

24

master contract shall require any physician or other person authorized by the department of health

25

to prescribe medication to prescribe from the formulary. A physician or other person authorized

26

by the department of health to prescribe medication shall be allowed to prescribe medications

27

previously on, or not on, the nonprofit dental service corporation's formulary if he or she believes

28

that the prescription of the non-formulary medication is medically necessary. A nonprofit dental

29

service corporation shall be required to provide coverage for a non-formulary medication only

30

when the non-formulary medication meets the nonprofit dental service corporation's medical

31

exception criteria for the coverage of that medication.

32

      (b) A nonprofit dental service corporation's medical exception criteria for the coverage

33

of non-formulary medications shall be developed in accordance with § 23-17.13-3(c)(3).

34

      (c) Any subscriber who is aggrieved by a denial of benefits to be provided under this

 

LC003117/SUB A - Page 4 of 6

1

section may appeal the denial in accordance with the rules and regulations promulgated by the

2

department of health pursuant to chapter 17.12 of title 23.

3

     (d) Prior to removing a prescription drug from its plan's formulary or making any change

4

in the preferred or tiered cost-sharing status of a covered prescription drug, a nonprofit dental

5

service corporation must provide at least thirty (30) days' notice to authorized prescribers by

6

established communication methods of policy and program updates and by updating available

7

references on web-based publications. All affected members must be provided at least thirty (30)

8

days' notice prior to the date such change becomes effective by a direct notification:

9

     (i) The written or electronic notice must contain the following information:

10

     (A) The name of the affected prescription drug;

11

     (B) Whether the plan is removing the prescription drug from the formulary, or changing

12

its preferred or tiered cost-sharing status; and

13

     (C) The means by which subscribers may obtain a coverage determination or medical

14

exception, in the case of drugs that will require prior authorization or are formulary exclusions

15

respectively.

16

     (ii) A nonprofit dental service corporation may immediately remove from their plan

17

formularies covered prescription drugs deemed unsafe by the nonprofit dental service corporation

18

or the Food and Drug Administration, or removed from the market by their manufacturer, without

19

meeting the requirements of this section.

20

     SECTION 5. Section 27-41-51 of the General Laws in Chapter 27-41 entitled "Health

21

Maintenance Organizations" is hereby amended to read as follows:

22

     27-41-51. Drug coverage. -- (a) Any health maintenance organization that utilizes a

23

formulary of medications for which coverage is provided under an individual or group plan

24

master contract shall require any physician or other person authorized by the department of health

25

to prescribe medication to prescribe from the formulary. A physician or other person authorized

26

by the department of health to prescribe medication shall be allowed to prescribe medications

27

previously on, or not on, the health maintenance organization's formulary if he or she believes

28

that the prescription of non-formulary medication is medically necessary. A health maintenance

29

organization shall be required to provide coverage for a non-formulary medication only when the

30

non-formulary medication meets the health maintenance organization's medical exception criteria

31

for the coverage of that medication.

32

      (b) A health maintenance organization's medical exception criteria for the coverage of

33

non-formulary medications shall be developed in accordance with § 23-17.13-3(c)(3).

34

      (c) Any subscriber who is aggrieved by a denial of benefits to be provided under this

 

LC003117/SUB A - Page 5 of 6

1

section may appeal the denial in accordance with the rules and regulations promulgated by the

2

department of health pursuant to chapter 17.12 of title 23.

3

     (d) Prior to removing a prescription drug from its plan's formulary or making any change

4

in the preferred or tiered cost-sharing status of a covered prescription drug, a health maintenance

5

organization must provide at least thirty (30) days' notice to authorized prescribers by established

6

communication methods of policy and program updates and by updating available references on

7

web-based publications. All affected members must be provided at least thirty (30) days' notice

8

prior to the date such change becomes effective by a direct notification:

9

     (i) The written or electronic notice must contain the following information:

10

     (A) The name of the affected prescription drug;

11

     (B) Whether the plan is removing the prescription drug from the formulary, or changing

12

its preferred or tiered cost-sharing status; and

13

     (C) The means by which subscribers may obtain a coverage determination or medical

14

exception, in the case of drugs that will require prior authorization or are formulary exclusions

15

respectively.

16

     (ii) A health maintenance organization may immediately remove from their plan

17

formularies covered prescription drugs deemed unsafe by the health maintenance organization or

18

the Food and Drug Administration, or removed from the market by their manufacturer, without

19

meeting the requirements of this section.

20

     SECTION 6. This act shall take effect on January 1, 2017.

========

LC003117/SUB A

========

 

LC003117/SUB A - Page 6 of 6

EXPLANATION

BY THE LEGISLATIVE COUNCIL

OF

A N   A C T

RELATING TO INSURANCE -- DRUG COVERAGE

***

1

     This act would require accident and sickness insurers, nonprofit hospital, medical and

2

dental service corporations and health maintenance organizations to give thirty (30) days' notice

3

to authorized prescribers by established communication methods and by updating available

4

references and web-based publications before making any change in preferred or tiered cost

5

sharing status of a covered drug. Any drug deemed unsafe by those entities or by the Food and

6

Drug Administration may be removed immediately without prior notice.

7

     This act would take effect on January 1, 2017.

========

LC003117/SUB A

========

 

LC003117/SUB A - Page 7 of 6